Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

MST — Predicate Candidate Screening

42 FDA 510(k) clearances under this product code; the 50 most recent screened below.

114 daysmedian FDA review time
280 days90th percentile
42clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K163177ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa EnhanImmco Diagnostics, Inc.2017-07-282560
K132082AESKULISA DGP-A, AESKULISA DGP-G,AESKULISA DGP-CHECKAesku Diagnostics2013-12-051530
K113377GLIADIN IGA AND GLIADIN LGAGrifols USA, LLC2012-12-143940
K113863QUANTA FLASH DGP IGA, QUANTA FLASH DGP IGG, QUANTA FLASH DGPInova Diagnostics, Inc.2012-09-202650
K111414QUANTA FLASH (TM) DGP SCREENInova Diagnostics, Inc.2011-10-201530
K093459ELIA GLIADIN DP IGA IMMUNOASSAY AND ELIA GLIADIN DP IGG IMMUPhadia US, Inc.2010-08-132802
K091522IMMULISA CELIAC G+ (GLIADIN) IGA AND IGG ANTIBODY ELISAImmco Diagnostics, Inc.2010-02-042580
K083053EUROIMMUN ANTI-GLIADIN (GAF-3X) ELISA (IGG)Euroimmun Us, Inc.2009-08-072970
K083052EUROIMMUN ANTI-GLIADIN (GAF-3X) ELISA (IGA)Euroimmun Us, Inc.2009-07-282870
K081674BINDAZYME HUMAN ANTI-GLIADIN (MGP), IGG EIA KIT; BINDAZYME HThe Binding Site, Ltd.2008-10-151200
K063775ELIA GLIADIN IGA, IGG AND CELIAC CONTROLPhadia US, Inc.2007-03-14830
K070083QUANTA LITE H-TTG/DGP SCREENInova Diagnostics, Inc.2007-03-12620
K062708QUANTA LITE CELIAC DGP SCREENInova Diagnostics, Inc.2006-12-13930
K053383FIDIS CELIACBiomedical Diagnostics (Bmd) SA2006-03-291140
K052793IMMUNOCAP/UNICAP GLIADIN IGA, IMMUNOCAP/UNICAP SPECIFIC IGA,Pharmacia Diagnostics AB2006-02-071270
K052439AESKULISA GLIA A AND AESKULISA GLIA GAesku Diagnostics2006-02-071540
K052143QUANTA LITE GLIADIN IGA IIInova Diagnostics, Inc.2005-10-04570
K052142QUANTA LITE GLIADIN IGG IIInova Diagnostics, Inc.2005-10-04570
K041002FIDIS CELIACBiomedical Diagnostics S.A.2004-09-241580
K041357VARELISA GLIADIN IGG ANTIBODIESSweden Diagnostics (Germany) GmbH2004-08-02740
K041354VARELISA GLIADIN IGA ANTIBODIES MODEL #19848/19896Sweden Diagnostics (Germany) GmbH2004-07-16570
K012797DIAMEDIX IS-ANTI-GLIADIN IGA TEST SYSTEMDiamedix Corp.2001-09-28380
K012795DIAMEDIX IS-ANTI-GLIADIN IGG TEST SYSTEMDiamedix Corp.2001-09-28381
K002169GLIADIN IGA ANTIBODY EIA DETECTION SYSTEMScimedx Corp.2000-10-19930
K002358MDI GLIADIN A TESTMicro Detect, Inc.2000-10-19780
K002189GLIADIN IGG ANTIBODY EIA DETECTION SYSTEMScimedx Corp.2000-10-19920
K002359MDI GLIADIN G TESTMicro Detect, Inc.2000-10-19780
K001393THE APTUS, AUTOMATED APPLICATION OF THE GLIADIN IGA ELISA TEZeus Scientific, Inc.2000-06-07350
K993250THE APTUS (AUTOMATED) APPLICATION OF THE GLIADIN IGG ELISA TZeus Scientific, Inc.1999-11-12450
K993087AUTOSTAT II ANTI-GLIADIN IGG ELISACogent Diagnotics , Ltd.1999-11-12580
K993086AUTOSTAT II ANTI-GLIADIN IGA ELISACogent Diagnotics , Ltd.1999-11-12580
K990204GLIADIN IGG ELISA TEST SYSTEMZeus Scientific, Inc.1999-03-26640
K990207GLIADIN IGA ELISA TEST SYSTEMZeus Scientific, Inc.1999-03-26640
K973910GLIADIN ANTIBODIES ELISAGenesis Diagnostics , Ltd.1999-02-174910
K982533UNICAP GLIADIN IGA ASSAYPharmacia & Upjohn Co.1998-10-22940
K982701UNICAP GLIADIN IGG ASSAYPharmacia & Upjohn Co.1998-10-22940
K981929BINDAZYME ANTIGLIADIN IGG/IGA COMBI KITThe Binding Site, Ltd.1998-09-031180
K981644BINDAZYME ANTIGLIADIN IGGThe Binding Site, Ltd.1998-09-031180
K964986QUANTA LITE IGA GLIADIN ELISAInova Diagnostics, Inc.1997-06-021710
K964985QUANTA LITE IGG GLIADIN ELISAInova Diagnostics, Inc.1997-05-301680
K964341IGA ANTI-GLIADIN (IGA-AGA) ANTIBODY TEST KITImmco Diagnostics, Inc.1997-05-302110
K964344IGG ANTI-GLIADIN (IGG-AGA) ANTIBODY TEST KITImmco Diagnostics, Inc.1997-05-302110

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda